A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: hold back (279), keep back (403), deny (12)

Apalutamide v1

Description
Chemotherapy Protocol PROSTATE APALUTAMIDE Regimen  Prostate cancer Indication  Apalutamide is recommended for non-metastatic prostate cancer as defined by recent imaging
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Apalutamide-v1.pdf

Cabozantinib

Description
Chemotherapy Protocol RENAL CELL CANCER Regimen CABOZANTINIB • Renal Cell – Cabozantinib (60mg-tablets) Indication • Cabozantinib s indicated for the treatment of advanced
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Cabozantinib.pdf

Lenalidomide Ver 1.1

Description
Chemotherapy Protocol LYMPHOMA LENALIDOMIDE There are multiple versions of this protocol in use. Please ensure you have the correct protoc
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lenalidomide-Ver-1.1.pdf

Brentuximab vedotin

Description
Chemotherapy Protocol LYMPHOMA BRENTUXIMAB VEDOTIN This protocol may require funding Regimen • Lymphoma – Brentuximab vedotin Indication • Hodgkin’s lymphoma • Systemic anaplastic large
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Brentuximab-vedotin.pdf

Bendamustine

Description
Chemotherapy Protocol LYMPHOMA BENDAMUSTINE There are multiple versions of this protocol in use. Please ensure you have the correct protocol for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine.pdf

Lenalidomide

Description
Chemotherapy Protocol MULTIPLE MYELOMA LENALIDOMIDE Regimen • Multiple Myeloma – Lenalidomide Indication • Lenalidomide is recommended, wi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Lenalidomide.pdf

Ipilimumab Ver 1

Description
Chemotherapy Protocol SKIN CANCER IPILIMUMAB Regimen Skin – Ipilimumab Indication Ipilimumab is recommended, within its marketing authorisation, as an option for treating
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinIpilimumabVer1.pdf

Cetuximab-Radiotherapy (7 day)

Description
Chemotherapy Protocol HEAD AND NECK CANCER CETUXIMAB RT (7 day) Regimen • Head and Neck Cancer – Cetuximab RT (7 day) Indication • Cetuximab
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cetuximab-Radiotherapy7day.pdf

ImatinibChronic

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (chronic phase) • CML – Imatinib (chronic phase) Indication • As the p
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibChronic.pdf

ImatinibAccelerated

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (accelerated phase) • CML - Imatinib (accelerated phase) Indication •
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibAccelerated.pdf
151 to 160 of 211
Previous … 14 15 16 17 18 … Next